This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Children's Medical Center Corporation. Active years: 2017-2023.
Company Filing History:
Years Active: 2017-2023
Title: Simon De Meyer: Innovator in Medical Technology
Introduction
Simon De Meyer is a notable inventor based in Zwevegem, Belgium. He has made significant contributions to the field of medical technology, particularly in the treatment and prevention of neutrophil-derived net toxicity and thrombosis. With a total of 4 patents to his name, De Meyer is recognized for his innovative approaches to addressing critical health issues.
Latest Patents
De Meyer's latest patents focus on methods for treating and preventing neutrophil-derived net toxicity and thrombosis. The technology described in these patents is based on the discovery that neutrophil extracellular traps (NETs) stimulate thrombus formation and are present in stored blood products. His work includes methods aimed at treating and preventing the toxicity of NETs and thrombosis caused by these traps. Additionally, he has developed methods for treating stored blood products to prevent transfusion-related injuries.
Career Highlights
Simon De Meyer is currently associated with the Children's Medical Center Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve patient outcomes in medical settings.
Collaborations
De Meyer collaborates with esteemed colleagues, including Denisa D Wagner and Alexander Brill, who contribute to his research endeavors and innovations in the medical field.
Conclusion
Simon De Meyer stands out as an influential inventor in medical technology, with a focus on improving treatments related to neutrophil-derived complications. His contributions are paving the way for advancements in healthcare and patient safety.